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Abstract
Glomerulopathy associated with recurrent or persistent proteinuria may lead to progressive tubulointerstitial fibrosis. Early detection of  tub-
ulointerstitial fibrosis may result in a more favorable outcome of  chronic kidney disease (CKD) because nephroprotective treatment may be 
instituted in due course. One of  the early markers of  tubulointerstitial fibrosis is glutathione S-transferase (GST). The aim of  this study was 
to determine urinary alpha-GST in children with idiopathic nephrotic syndrome (INS), either in remission or relapse. This case–control study 
included 40 children with primary nephrotic syndrome (NS), either in remission or relapse. Also, 40 healthy children, age- and sex-matched 
as controls, were selected from the outpatients and the pediatric nephrology unit of  Al-Zahraa Hospital, Al-Azhar University. Urinary alpha-
GST was investigated in the study groups on the same lines as that of  routine investigations of  INS. Children with INS have significantly 
higher urinary GST either in remission or relapse, it was (5.23 ± 1.90) ng/mL, (5.32 ± 1.52) ng/mL respectively compared with healthy con-
trols, it was (2.59 ± 1.12) ng/mL with (P = 0.001). A positive correlation between urinary alpha-GST and body weight BW, height, body mass 
index (BMI), white blood cells (WBCs) count, erythrocyte sedimentation rate, serum (cholesterol, triglyceride [TG]) level, blood urea nitrogen 
(BUN), and duration of  the disease. Urinary alpha-GST was increased in children with NS even after remission, and it consequently led to 
oxidative stress and tubulointerstitial fibrosis. Nephroprotective treatment is recommended even in cases with INS, either in remission or 
relapse.
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Introduction
Nephrotic syndrome (NS) is a common renal disorder with sig-
nificant tubulointerstitial damage due to the combined effects 
of proteinuria and obstruction of efferent blood flow (1).
Tubulointerstitial fibrosis and tubular atrophy play a 
crucial role in the pathogenesis of chronic kidney disease 
(CKD). They are also major determinants in CKD develop-
ment and progression in patients with primary renal diseases, 
characterized by persistent or recurrent proteinuria. Early 
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• All children included in the study were subjected to history 
taking, clinical examination, and laboratory investigations.
• Investigations:
A) Routine investigations: Urinary albumin-to-creatinine 
ratio: Nephrotic levels of proteinuria are associated 
with a ratio of urinary protein to urinary creatinine 
of >2 mg/dL (7). Complete blood count, erythrocyte 
sedimentation rate (ESR), serum urea, creatinine, Na, 
K, albumin, cholesterol and triglyceride, abdominal 
ultrasound, and renal biopsy results were taken from 
the patient’s file.
B) Specific investigations:
 Assessment of urinary alpha-GST of all studied chil-
dren, enzyme-linked immunosorbent assay (ELISA) 
was performed.
• Urine sampling: The midstream of the first morning urine 
specimen was collected and preserved with stabilizing buf-
fer at -20°C till the time of the test.
• Principle of the test:
 Use the kit assay to assess the human alpha-GST level 
in the sample; use purified human alpha-GST to coat 
microtiter plate wells; make solid-phase antibody; add 
alpha-GST to wells; combine alpha-GST antibody with 
Horseradish Peroxidase  (HRP) labeled to form anti-
body–antigen–enzyme–antibody complex; after washing 
completely, add Tetramethylbenzidine (TMB) substrate 
solution. The TMB substrate turns blue in color at HRP 
enzyme-catalyzed, and the reaction is terminated by the 
addition of sulfuric acid solution, with the color change 
measured spectrophotometrically at a wavelength of 450 
nm. The concentration of alpha-GST in the samples is 
then determined by comparing the optical density (OD) 
of the samples to the standard curve (WKEA MED SUP-
PLIES CORP; www.wkeamedsupplies.com).
Statistical analysis
Data were collected, revised, coded, and entered into the Sta-
tistical Package for Social Science (IBM SPSS) version 20. 
Spearman correlation coefficients were used to assess the 
correlation between two quantitative parameters in the same 
group. The P-value was considered significant as the following: 
P > 0.05: nonsignificant; P < 0.05: significant; and P < 0.01: 
highly significant.
Results
Table 1 revealed a significant increase in blood pressure, 
WBCs, ESR, and Hb levels in the patient group, compared 
to the control group, while there is no significant difference 
in the CRP level between both the groups. Table 2 revealed 
a significant increase in the serum level of cholesterol, tri-
glycerides, and BUN in the patient group, compared to the 
detection of tubulointerstitial fibrosis may result in a more 
favorable outcome of CKD because nephroprotective treat-
ment may be instituted (2).
Numerous studies on novel early markers of  tubulointer-
stitial fibrosis have been published. One of  the early mark-
ers of  tubulointerstitial fibrosis is glutathione S-transferase 
(GST). It is a cytosolic enzyme. There are many isoforms of 
GST. The alpha and pi isoforms of  GST (alpha-GST and 
pi-GST) are typical of  the human kidney. The alpha-GST 
is expressed in proximal tubular epithelial cells, whereas 
the pi-GST is specific to distal tubular epithelial cells (3, 
4). Following tubular damage, GSTs are released into the 
urine (5).
Increased urinary GST excretions are reported in the early 
phase of acute tubular injury caused by various toxic sub-
stances and after cardiac surgery. Urinary GST excretions 
can be used as an early marker of tubular injury in glomeru-
lopathies (3).
We aimed to assess the urinary GST level as a marker of oxi-
dative stress and tubulointerstitial fibrosis in children with idio-
pathic nephrotic syndrome (INS), either in remission or relapse.
Subjects and Methods
This case–control study was carried out on 60 children, 40 
males and 20 females, aged from 4 to 18 years, selected from 
those attending the outpatient pediatric clinic and the inpa-
tients of the pediatric nephrology unit of Al-Zahraa Hospi-
tal, Al-Azhar University. Children included in the study were 
divided into the following two groups:
Group I: patients group. Forty children with INS, 33 males 
and seven females, aged between 4 and 18 years, formed 
the patient group. They were either in remission or relapse. 
The criteria of complete remission are proteinuria of <40 
mg/m2/hour, at least on 3 consecutive days within a period 
of 7 days, and serum albumin of ≥3.5 g/dL. The criteria of 
relapse are urinary protein excretion of >40 mg/m2/hour or 
albustix of 3+ or more for three consecutive days and having 
previously been in remission (6). Twenty-nine (72.5%) of the 
patients were in remission and 11 (27.5%) were in relapse. 
Steroid-sensitive NS is the most common type (57.5%) of 
NS according to clinical classification of the study group. 
The minimal change is of  the communist type according to 
the histological classification of 13 cases (59%), followed by 
focal segmental glomerulosclerosis in four cases (18%) and 
focal proliferative GN in three cases (13%). Meanwhile in 
18 cases (45.0%) of the patient group, renal biopsy was not 
indicated.
Group II: control group. Twenty healthy children age- and 
sex-matched with the group I. Children with secondary NS, 
autoimmune diseases, other causes of generalized edema, 
acute kidney disease or CKDs, and cardiac surgery were 
excluded from the study.
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Table 1: Comparison between patient group and control group regarding demographic date, blood pressure, complete blood 






Mean ± SD Mean ± SD t P
Age (years) 8.58 ± 3.90 6.70 ± 3.04 1.882 0.065
Females 7 (17.5%) 8 (40.0%)
Males 33 (82.5%) 12 (60.0%) 2.602 0.012
Diastolic BP mmHg 66.88 ± 8.14 61.00 ± 4.47 3.001 0.004
WBCs (103/uL) 10.09 ± 3.76 7.56 ± 1.24 2.923 0.005
RBCs (106/uL) 4.58 ± 0.59 4.83 ± 0.42 -1.676 0.099
Hb gm/dL 13.31 ± 1.42 11.91 ± 0.75 4.130 0.001
Hct% 37.30 ± 3.03 36.63 ± 2.45 0.854 0.397
Platelet (103/uL) 313.73 ± 97.09 285.60 ± 54.49 1.201 0.235
ESR mm/1sth
Median (IQR)
31.5 (23–53.5) 15 (12–19.5) 5.486 0.001
CRP mg/L <6>6 39 (97.5%) 20 (100.0%) 0.508 0.476
WBC, white blood cell; RBC, red blood cell, BP, blood pressure; ESR, erythrocyte sedimentation rate; IQR, interquartile range; CRP, 
C-reactive protein; Hct, hematocrit; Hb, hemoglobin. 






Mean ± SD Mean ± SD t P
Cholesterol mg/dL 288.48 ± 107.99 64.95 ± 16.23 9.167 0.001
TG mg/dL 153.88 ± 50.85 45.05 ± 6.58 9.492 0.001
BUN mg/dL 27.73 ± 9.67 13.60 ± 4.22 6.221 0.001
Creat mg/dL 0.44 ± 0.11 0.43 ± 0.07 0.460 0.647
Serum Alb mg/dL 3.34 ± 1.02 4.14 ± 0.39 -3.371 0.001
GFRml/min/1.73m2 155.93 ± 28.17 147.70 ± 28.91 1.057 0.295
Urinary alpha-GST ng/mL 5.26 ± 1.79 2.59 ± 1.12 6.085 0.001
TG, triglyceride; Creat, creatinine; BUN, blood urea nitrogen; Alb, albumin; GFR, glomerular filtration rate; GST, glutathione 
S-transferase.
control group, while there is a significant decrease in the 
serum albumen and urinary alpha-GST levels in the patient 
group, compared to the control group. Table 3 revealed that 
there is no significant difference between clinical types with 
regard to urinary alpha-GST levels.
Figure 1 shows a significant positive correlation between uri-
nary alpha-GST and systolic blood pressure. Figure 2 shows 
a significant positive correlation between urinary alpha-GST 
and WBCs. Figure 3 shows a significant positive correlation 
between urinary alpha-GST and the level of triglyceride serum. 
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Table 3: Comparison between nephrotic syndrome clinical types with regard to urinary alpha glutathione S-transferase level.
Variable Urinary alpha-GST ng/mL Independent t-test
Mean ± SD Range t P
SSNS (n = 23) 5.18 ± 1.96 2 – 8.4 0.384 0.703
SRNS (n = 16) 5.41 ± 1.47 2.1 – 7.3
Remission (n = 29) 5.23 ± 1.90 2 – 8.4 0.131 0.897
Relapse (n = 11) 5.32 ± 1.52 2 – 7
SSNS, steroid sensitive nephrotic syndrome; GST, glutathione-S-Transferase; SRNS: steroid resistant nephrotic syndrome.
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Figure 1: Correlation between urinary alpha glutathione 

















r = 0.479 p = 0.002
Figure 2: Correlation between urinary alpha glutathione 
S-transferase and white blood cells.
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Figure 3: Correlation between urinary alpha glutathione S-transferase and triglyceride serum level.
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Figure 4 shows a significant positive correlation between 
urinary alpha-GST and urea. Figure 5 shows a correlation 
between urinary alpha-GST and the duration of NS.
Discussion
Different studies have successfully investigated the role of 
several markers for detecting tubulointerstitial fibrosis in 
renal diseases. Regarding GST and NS, only one study was 
conducted on urinary alpha-GST level in NS; hence, not 
much data were available on this issue as per the comprehen-
sive electronic survey.
In the current study, we found a significant increase in uri-
nary alpha-GST excretion in all the participants with NS in 
comparison to the control group. The number of patients 
with remission and relapse was 29 (72.5%) and 11 (27.5%), 
respectively; surprisingly we found no significant difference 
between children with NS, either in remission or relapse, with 
regard to urinary alpha-GST level.
Urinary GST increases might represent subclinical renal 
tubular injury and/or a tubular response to oxidant stress; 
oxidative stress persisted in NS even after remission, and 
deoxyribonucleic (DNA) damage can occur as a result of 
persistent oxidant stress. GST can be used as a marker in NS 
and as an indicator of oxidative stress (8).
Isoforms of GST and glutaredoxin (Grx) play a significant 
role in the regulation of cell signaling by protein-to-protein 
interactions, with regulatory kinases controlling the cell 
response to stress, proliferation, and induction of apopto-
sis (9–11). GST enzymes protect cells against reactive oxy-
gen species (ROS), which is important for preventing DNA 
Figure 4: Correlation between urinary alpha glutathione 
S-transferase and blood urea nitrogen.
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Figure 5. Correlation between urinary alpha glutathione 
S-transferase and duration of nephrotic syndrome.
damage (12). The expression of GSTs can be regulated by 
different stressors (e.g., variation in temperature, oxidative 
damage, and exposure to toxins), and cytosolic glutathi-
one transferases (cGSTs) promoters contain antioxidant 
response elements (13, 14).
Fan et al. (15) reported a significant increase in oxidative 
stress markers, malondialdehyde (MDA) and superoxide dis-
mutase (SOD), in children at first presentation and after 4 
weeks of steroid treatment.
From my point of view, the current research, and others, chil-
dren with NS are exposed to oxidative stress even after remission.
We reported a significant positive correlation between 
urinary alpha-GST and the prolonged disease length. This 
association may relate to the prolonged generation of oxida-
tive stress; also, prolonged exposure to proteinuria can cause 
tubulointerstitial fibrosis through the induction of tubular 
chemokines expression and complement activation that leads 
to inflammatory cell infiltration in the interstitium and sus-
tained fibrogenesis. Chemoattractants and adhesive mole-
cules for inflammatory cells are upregulated by an excessive 
ultrafiltrate protein load of proximal tubular cells (16).
A significant positive correlation between urinary alpha-
GST level and body weight & BMI was reported in the 
present study; obesity is a state of mild inflammation and 
oxidative stress that increases the release of GST (17, 18). 
Also, cholesterol and TG were positively correlated with uri-
nary alpha-GST; abnormal lipid homeostasis may contribute 
to the pathogenesis of renal fibrosis and vascular calcifica-
tion (19–21). Lipids are susceptible to oxidation, and lipid 
peroxidation products are potential biomarkers for oxidative 
stress status in vivo and its related diseases (22).
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There was no correlation between urinary alpha-GST 
excretion and the magnitude of proteinuria. This observa-
tion suggests that renal tubular injury due to proteinuria 
seems to be independent of its magnitude. In the study by 
Bashir et al. (23), urinary alpha-GST and pi-GST excretions 
were suggested to be useful markers of proteinuria-induced 
renal tubular injury. They also revealed a positive correla-
tion between urinary alpha-GST excretion and the severity 
of proximal tubular histopathologic changes. They proved 
that in proteinuric patients, the initial injury was localized 
in proximal tubules. Our results also confirmed this observa-
tion. This might indicate that in children with NS, regardless 
of clinical types, renal tubular injury begins in the region of 
proximal tubules.
Cawood et al. (24) observed that in diabetic proteinuric 
patients, urinary alpha- and pi-GST markers appeared to 
identify renal damage, which was related to but distinct from 
albuminuria.
A significant correlation between alpha-GST and hyper-
tension was detected, which decreased renal blood flow, 
resulting in increased mitochondrial oxygen use, shunting of 
blood from arterial to venous blood in preglomerular vessels, 
the release of cytokines, presence of oxidative stress, and the 
release of ROS (25).
In conclusion, oxidative stress persists in children with 
INS even after remission, which is evidenced by elevated 
GST; thus, nephroprotective treatment should be intensified. 
In the future, larger studies will be required to further vali-
date these findings.
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